APO Research
Talk to an analyst

APO RESEARCH · REPORT

Intestinal Ascariasis Medicine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Intestinal Ascariasis Medicine Market Analysis and Forecast 2026-2032

19 December 2025194 pages

Choose your research edition.

Industry ResearchIntestinal Ascariasis Medicine Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Intestinal Ascariasis Medicine Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Intestinal Ascariasis Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Intestinal Ascariasis Medicine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Intestinal Ascariasis Medicine Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Intestinal Ascariasis Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Intestinal Ascariasis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Intestinal Ascariasis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Intestinal Ascariasis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Intestinal Ascariasis Medicine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Intestinal Ascariasis Medicine include Actavis, Bayer HealthCare, Bullvet, Cipla, Endo Pharmaceuticals, Henan Sino New Energy Material, Inject Care Parenterals, Purdue Pharma and Pfizer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Intestinal Ascariasis Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Intestinal Ascariasis Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Intestinal Ascariasis Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Intestinal Ascariasis Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Intestinal Ascariasis Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Intestinal Ascariasis Medicine revenue, projected growth trends, production technology, application and end-user industry.

Intestinal Ascariasis Medicine Segment by Company

Actavis

Bayer HealthCare

Bullvet

Cipla

Endo Pharmaceuticals

Henan Sino New Energy Material

Inject Care Parenterals

Purdue Pharma

Pfizer

Novartis

Johnson & Johnson

Sanofi

Sun Pharmaceutical Industries

Intestinal Ascariasis Medicine Segment by Type

Painkiller

Piperazine Citrate

Complication Treatment Drug

Others

Intestinal Ascariasis Medicine Segment by Application

Patients With Ulcer Disease

Complication Treatment

Others

Intestinal Ascariasis Medicine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Intestinal Ascariasis Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Intestinal Ascariasis Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Intestinal Ascariasis Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Intestinal Ascariasis Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Intestinal Ascariasis Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Intestinal Ascariasis Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Painkiller Major Player Table 3. Piperazine Citrate Major Player Table 4. Complication Treatment Drug Major Player Table 5. Others Major Player Table 6. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Patients With Ulcer Disease Major Player Table 8. Complication Treatment Major Player Table 9. Others Major Player Table 10. Intestinal Ascariasis Medicine Industry Trends Table 11. Intestinal Ascariasis Medicine Industry Drivers Table 12. Intestinal Ascariasis Medicine Industry Opportunities and Challenges Table 13. Intestinal Ascariasis Medicine Industry Restraints Table 14. Global Intestinal Ascariasis Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Intestinal Ascariasis Medicine Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Intestinal Ascariasis Medicine Market Share by Region (2021-2026) Table 17. Global Intestinal Ascariasis Medicine Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Intestinal Ascariasis Medicine Market Share by Region (2027-2032) Table 19. Global Intestinal Ascariasis Medicine Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Intestinal Ascariasis Medicine Revenue Market Share by Players (2021-2026) Table 21. Global Intestinal Ascariasis Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Intestinal Ascariasis Medicine Key Players Headquarters & Area Served Table 23. Global Intestinal Ascariasis Medicine Players, Product Type & Application Table 24. Global Intestinal Ascariasis Medicine Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Intestinal Ascariasis Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Intestinal Ascariasis Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2021-2026) Table 31. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2027-2032) Table 32. Global Intestinal Ascariasis Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2021-2026) Table 36. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2027-2032) Table 37. Actavis Company Information Table 38. Actavis Business Overview Table 39. Actavis Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Actavis Intestinal Ascariasis Medicine Product Portfolio Table 41. Actavis Recent Development Table 42. Bayer HealthCare Company Information Table 43. Bayer HealthCare Business Overview Table 44. Bayer HealthCare Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Bayer HealthCare Intestinal Ascariasis Medicine Product Portfolio Table 46. Bayer HealthCare Recent Development Table 47. Bullvet Company Information Table 48. Bullvet Business Overview Table 49. Bullvet Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Bullvet Intestinal Ascariasis Medicine Product Portfolio Table 51. Bullvet Recent Development Table 52. Cipla Company Information Table 53. Cipla Business Overview Table 54. Cipla Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Cipla Intestinal Ascariasis Medicine Product Portfolio Table 56. Cipla Recent Development Table 57. Endo Pharmaceuticals Company Information Table 58. Endo Pharmaceuticals Business Overview Table 59. Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Endo Pharmaceuticals Intestinal Ascariasis Medicine Product Portfolio Table 61. Endo Pharmaceuticals Recent Development Table 62. Henan Sino New Energy Material Company Information Table 63. Henan Sino New Energy Material Business Overview Table 64. Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Henan Sino New Energy Material Intestinal Ascariasis Medicine Product Portfolio Table 66. Henan Sino New Energy Material Recent Development Table 67. Inject Care Parenterals Company Information Table 68. Inject Care Parenterals Business Overview Table 69. Inject Care Parenterals Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Inject Care Parenterals Intestinal Ascariasis Medicine Product Portfolio Table 71. Inject Care Parenterals Recent Development Table 72. Purdue Pharma Company Information Table 73. Purdue Pharma Business Overview Table 74. Purdue Pharma Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Purdue Pharma Intestinal Ascariasis Medicine Product Portfolio Table 76. Purdue Pharma Recent Development Table 77. Pfizer Company Information Table 78. Pfizer Business Overview Table 79. Pfizer Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Pfizer Intestinal Ascariasis Medicine Product Portfolio Table 81. Pfizer Recent Development Table 82. Novartis Company Information Table 83. Novartis Business Overview Table 84. Novartis Intestinal Ascariasis Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Novartis Intestinal Ascariasis Medicine Product Portfolio Table 86. Novartis Recent Development Table 87. Johnson & Johnson Company Information Table 88. Johnson & Johnson Business Overview Table 89. Johnson & Johnson Intestinal Ascariasis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Johnson & Johnson Intestinal Ascariasis Medicine Product Portfolio Table 91. Johnson & Johnson Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Intestinal Ascariasis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Sanofi Intestinal Ascariasis Medicine Product Portfolio Table 96. Sanofi Recent Development Table 97. Sun Pharmaceutical Industries Company Information Table 98. Sun Pharmaceutical Industries Business Overview Table 99. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product Portfolio Table 101. Sun Pharmaceutical Industries Recent Development Table 102. North America Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 107. North America Intestinal Ascariasis Medicine Revenue by Country (2021-2026) & (US$ Million) Table 108. North America Intestinal Ascariasis Medicine Revenue by Country (US$ Million) & (2027-2032) Table 109. Europe Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 110. Europe Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 111. Europe Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 112. Europe Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 113. Europe Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Europe Intestinal Ascariasis Medicine Revenue by Country (2021-2026) & (US$ Million) Table 115. Europe Intestinal Ascariasis Medicine Revenue by Country (US$ Million) & (2027-2032) Table 116. China Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 117. China Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 118. China Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 119. China Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 120. Asia Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 121. Asia Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 122. Asia Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 123. Asia Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 124. Asia Intestinal Ascariasis Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 125. Asia Intestinal Ascariasis Medicine Revenue by Region (US$ Million) & (2021-2026) Table 126. Asia Intestinal Ascariasis Medicine Revenue by Region (US$ Million) & (2027-2032) Table 127. SAMEA Intestinal Ascariasis Medicine Revenue by Type (2021-2026) & (US$ Million) Table 128. SAMEA Intestinal Ascariasis Medicine Revenue by Type (2027-2032) & (US$ Million) Table 129. SAMEA Intestinal Ascariasis Medicine Revenue by Application (2021-2026) & (US$ Million) Table 130. SAMEA Intestinal Ascariasis Medicine Revenue by Application (2027-2032) & (US$ Million) Table 131. SAMEA Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. SAMEA Intestinal Ascariasis Medicine Revenue by Country (2021-2026) & (US$ Million) Table 133. SAMEA Intestinal Ascariasis Medicine Revenue by Country (US$ Million) & (2027-2032) Table 134. Research Programs/Design for This Report Table 135. Authors List of This Report Table 136. Secondary Sources Table 137. Primary Sources List of Figures Figure 1. Intestinal Ascariasis Medicine Image Figure 2. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Intestinal Ascariasis Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Painkiller Image Figure 5. Piperazine Citrate Image Figure 6. Complication Treatment Drug Image Figure 7. Others Image Figure 8. Global Intestinal Ascariasis Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Intestinal Ascariasis Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Patients With Ulcer Disease Image Figure 11. Complication Treatment Image Figure 12. Others Image Figure 13. Global Intestinal Ascariasis Medicine Market Size (US$ Million) & (2021-2032) Figure 14. Global Intestinal Ascariasis Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Intestinal Ascariasis Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Intestinal Ascariasis Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Intestinal Ascariasis Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Intestinal Ascariasis Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2021-2032) Figure 21. Global Intestinal Ascariasis Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2021-2032) Figure 24. North America Intestinal Ascariasis Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032) Figure 26. North America Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032) Figure 27. North America Intestinal Ascariasis Medicine Revenue Share by Country (2021-2032) Figure 28. United States Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Intestinal Ascariasis Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032) Figure 33. Europe Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032) Figure 34. Europe Intestinal Ascariasis Medicine Revenue Share by Country (2021-2032) Figure 35. Germany Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Intestinal Ascariasis Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032) Figure 45. China Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032) Figure 46. Asia Intestinal Ascariasis Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032) Figure 48. Asia Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032) Figure 49. Asia Intestinal Ascariasis Medicine Revenue Share by Region (2021-2032) Figure 50. Japan Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Intestinal Ascariasis Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032) Figure 58. SAMEA Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032) Figure 59. SAMEA Intestinal Ascariasis Medicine Revenue Share by Country (2021-2032) Figure 60. Brazil Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Intestinal Ascariasis Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Painkiller
  • Piperazine Citrate
  • Complication Treatment Drug
  • Others
Applications
  • Patients With Ulcer Disease
  • Complication Treatment
  • Others
Companies covered
  • Actavis
  • Bayer HealthCare
  • Bullvet
  • Cipla
  • Endo Pharmaceuticals
  • Henan Sino New Energy Material
  • Inject Care Parenterals
  • Purdue Pharma
  • Pfizer
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Sun Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Intestinal Ascariasis Medicine Market by Type
  3. 1.2.1 Global Intestinal Ascariasis Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Painkiller
  5. 1.2.3 Piperazine Citrate
  6. 1.2.4 Complication Treatment Drug
  7. 1.2.5 Others
  8. 1.3 Intestinal Ascariasis Medicine Market by Application
  9. 1.3.1 Global Intestinal Ascariasis Medicine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Patients With Ulcer Disease
  11. 1.3.3 Complication Treatment
  12. 1.3.4 Others
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Intestinal Ascariasis Medicine Market Dynamics
  1. 2.1 Intestinal Ascariasis Medicine Industry Trends
  2. 2.2 Intestinal Ascariasis Medicine Industry Drivers
  3. 2.3 Intestinal Ascariasis Medicine Industry Opportunities and Challenges
  4. 2.4 Intestinal Ascariasis Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Intestinal Ascariasis Medicine Market Perspective (2021-2032)
  2. 3.2 Global Intestinal Ascariasis Medicine Growth Trends by Region
  3. 3.2.1 Global Intestinal Ascariasis Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Intestinal Ascariasis Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Intestinal Ascariasis Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Intestinal Ascariasis Medicine Revenue by Players
  2. 4.1.1 Global Intestinal Ascariasis Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Intestinal Ascariasis Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Intestinal Ascariasis Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Intestinal Ascariasis Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Intestinal Ascariasis Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Intestinal Ascariasis Medicine Players, Product Type & Application
  8. 4.5 Global Intestinal Ascariasis Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Intestinal Ascariasis Medicine Market CR5 and HHI
  11. 4.6.3 2025 Intestinal Ascariasis Medicine Tier 1, Tier 2, and Tier 3
5 Intestinal Ascariasis Medicine Market Size by Type
  1. 5.1 Global Intestinal Ascariasis Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Intestinal Ascariasis Medicine Revenue Market Share by Type (2021-2032)
6 Intestinal Ascariasis Medicine Market Size by Application
  1. 6.1 Global Intestinal Ascariasis Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Intestinal Ascariasis Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Actavis
  2. 7.1.1 Actavis Company Information
  3. 7.1.2 Actavis Business Overview
  4. 7.1.3 Actavis Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Actavis Intestinal Ascariasis Medicine Product Portfolio
  6. 7.1.5 Actavis Recent Developments
  7. 7.2 Bayer HealthCare
  8. 7.2.1 Bayer HealthCare Company Information
  9. 7.2.2 Bayer HealthCare Business Overview
  10. 7.2.3 Bayer HealthCare Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bayer HealthCare Intestinal Ascariasis Medicine Product Portfolio
  12. 7.2.5 Bayer HealthCare Recent Developments
  13. 7.3 Bullvet
  14. 7.3.1 Bullvet Company Information
  15. 7.3.2 Bullvet Business Overview
  16. 7.3.3 Bullvet Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Bullvet Intestinal Ascariasis Medicine Product Portfolio
  18. 7.3.5 Bullvet Recent Developments
  19. 7.4 Cipla
  20. 7.4.1 Cipla Company Information
  21. 7.4.2 Cipla Business Overview
  22. 7.4.3 Cipla Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Cipla Intestinal Ascariasis Medicine Product Portfolio
  24. 7.4.5 Cipla Recent Developments
  25. 7.5 Endo Pharmaceuticals
  26. 7.5.1 Endo Pharmaceuticals Company Information
  27. 7.5.2 Endo Pharmaceuticals Business Overview
  28. 7.5.3 Endo Pharmaceuticals Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Endo Pharmaceuticals Intestinal Ascariasis Medicine Product Portfolio
  30. 7.5.5 Endo Pharmaceuticals Recent Developments
  31. 7.6 Henan Sino New Energy Material
  32. 7.6.1 Henan Sino New Energy Material Company Information
  33. 7.6.2 Henan Sino New Energy Material Business Overview
  34. 7.6.3 Henan Sino New Energy Material Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Henan Sino New Energy Material Intestinal Ascariasis Medicine Product Portfolio
  36. 7.6.5 Henan Sino New Energy Material Recent Developments
  37. 7.7 Inject Care Parenterals
  38. 7.7.1 Inject Care Parenterals Company Information
  39. 7.7.2 Inject Care Parenterals Business Overview
  40. 7.7.3 Inject Care Parenterals Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Inject Care Parenterals Intestinal Ascariasis Medicine Product Portfolio
  42. 7.7.5 Inject Care Parenterals Recent Developments
  43. 7.8 Purdue Pharma
  44. 7.8.1 Purdue Pharma Company Information
  45. 7.8.2 Purdue Pharma Business Overview
  46. 7.8.3 Purdue Pharma Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Purdue Pharma Intestinal Ascariasis Medicine Product Portfolio
  48. 7.8.5 Purdue Pharma Recent Developments
  49. 7.9 Pfizer
  50. 7.9.1 Pfizer Company Information
  51. 7.9.2 Pfizer Business Overview
  52. 7.9.3 Pfizer Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Pfizer Intestinal Ascariasis Medicine Product Portfolio
  54. 7.9.5 Pfizer Recent Developments
  55. 7.10 Novartis
  56. 7.10.1 Novartis Company Information
  57. 7.10.2 Novartis Business Overview
  58. 7.10.3 Novartis Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Novartis Intestinal Ascariasis Medicine Product Portfolio
  60. 7.10.5 Novartis Recent Developments
  61. 7.11 Johnson & Johnson
  62. 7.11.1 Johnson & Johnson Company Information
  63. 7.11.2 Johnson & Johnson Business Overview
  64. 7.11.3 Johnson & Johnson Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Johnson & Johnson Intestinal Ascariasis Medicine Product Portfolio
  66. 7.11.5 Johnson & Johnson Recent Developments
  67. 7.12 Sanofi
  68. 7.12.1 Sanofi Company Information
  69. 7.12.2 Sanofi Business Overview
  70. 7.12.3 Sanofi Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Sanofi Intestinal Ascariasis Medicine Product Portfolio
  72. 7.12.5 Sanofi Recent Developments
  73. 7.13 Sun Pharmaceutical Industries
  74. 7.13.1 Sun Pharmaceutical Industries Company Information
  75. 7.13.2 Sun Pharmaceutical Industries Business Overview
  76. 7.13.3 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Sun Pharmaceutical Industries Intestinal Ascariasis Medicine Product Portfolio
  78. 7.13.5 Sun Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Intestinal Ascariasis Medicine Revenue (2021-2032)
  2. 8.2 North America Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Intestinal Ascariasis Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Intestinal Ascariasis Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Intestinal Ascariasis Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Intestinal Ascariasis Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Intestinal Ascariasis Medicine Revenue by Country
  11. 8.6.1 North America Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Intestinal Ascariasis Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Intestinal Ascariasis Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Intestinal Ascariasis Medicine Revenue (2021-2032)
  2. 9.2 Europe Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Intestinal Ascariasis Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Intestinal Ascariasis Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Intestinal Ascariasis Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Intestinal Ascariasis Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Intestinal Ascariasis Medicine Revenue by Country
  11. 9.6.1 Europe Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Intestinal Ascariasis Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Intestinal Ascariasis Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
10 China
  1. 10.1 China Intestinal Ascariasis Medicine Revenue (2021-2032)
  2. 10.2 China Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Intestinal Ascariasis Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Intestinal Ascariasis Medicine Revenue by Type (2027-2032)
  5. 10.3 China Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Intestinal Ascariasis Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Intestinal Ascariasis Medicine Revenue by Application (2027-2032)
  9. 10.5 China Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Intestinal Ascariasis Medicine Revenue (2021-2032)
  2. 11.2 Asia Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Intestinal Ascariasis Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Intestinal Ascariasis Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Intestinal Ascariasis Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Intestinal Ascariasis Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Intestinal Ascariasis Medicine Revenue by Country
  11. 11.6.1 Asia Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Intestinal Ascariasis Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Intestinal Ascariasis Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Intestinal Ascariasis Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Intestinal Ascariasis Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Intestinal Ascariasis Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Intestinal Ascariasis Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Intestinal Ascariasis Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Intestinal Ascariasis Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Intestinal Ascariasis Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Intestinal Ascariasis Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Intestinal Ascariasis Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Intestinal Ascariasis Medicine Revenue by Country
  11. 12.6.1 SAMEA Intestinal Ascariasis Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Intestinal Ascariasis Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Intestinal Ascariasis Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst